The interaction of dihydromyricetin (DMY) and -amylase was investigated. The complex formed between DMY and -amylase resulted in decreased antioxidant activity of DMY and the catalytic activity of the enzyme, as well as efficient quenching of the intrinsic fluorescence of -amylase. An -amylase molecule provides one binding site for a DMY molecule. These results will be useful for exploiting this compound to combat diseases efficiently.
Many studies have demonstrated that flavonoids and enzymes can combine to form soluble or insoluble complexes through noncovalent interactions. Such complexes have been characterized by many changes in their physicochemcial and structural properties, as well as the biological activities of the enzymes and flavonoids [1] [2] [3] [4] [5] . Dihydromyricetin (DMY), which is the main active component from Ampelopsis grossedentata, has many properties, including antioxidant, antitumor, reducing blood pressure, anti-inflammatory, and anti-hypertension, which makes it a potential source of natural nutraceuticals for the food and pharmaceutical industries [6] [7] .
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels. Control of the blood glucose level, especially postprandial, is an effective way to mitigate and prevent the illnesses of hyperglycemia and diabetes. α-Amylase is a key enzyme in the digestive system and catalyzes the initial step in the hydrolysis of starch. It has been proposed that inhibition of α-amylase can effectively control the postprandial elevation of the blood glucose level [8] [9] [10] . Studies have shown that flavonoids could inhibit -amylase activity and then exert an antihyperglycemic and protective effect against the development of diabetes [11] [12] [13] . However, little is known about how DMY interacts with -amylase and further influences the antioxidant and catalytic activities of the enzyme. Therefore, it would be interesting to investigate the interaction between DMY and -amylase to understand how this compound can be efficiently exploited to combat diseases. Accordingly, the objective of this current study was to investigate the interaction between DMY and -amylase, which includes the influence of this interaction on the antioxidant activity of DMY, its catalytic activity, and the intrinsic fluorescence of the enzyme.
Early studies showed that flavonoids may change the catalytic activity of an enzyme by binding with zymoprotein through hydrophobic interaction and hydrogen bonds. It is clear that the structure and concentration of flavonoids, as well as the amino acid composition and structure of zymoprotein may greatly influence the extent of the flavonoid/enzyme binding [14] .
DMY demonstrated significant inhibition of the catalytic activity of -amylase, as shown in Figure 1 . It was noted that the inhibition (from 13.5% to 48.1%) was positively associated with increasing DMY concentration (from 0.33 to 1.67 mg/mL).
The interaction with -amylase also influenced the antioxidant activity of DMY. As shown in Figure 2 , the ABTS
•+ , DPPH scavenging activity and reducing power of DMY decreased in the presence of -amylase in an obvious dose-dependent manner. Antioxidant activity plays a major role in the biological behavior of many flavonoids [5] . Thus, the interaction with -amylase might impair the other bioactivities of DMY.
The interaction between DMY and -amylase was further confirmed by an intrinsic fluorescence study. Fluorescence spectroscopy techniques can give detailed information on the binding of small molecules to protein at the molecular level in terms of the binding mechanism, binding mode, binding constants and others [15] . Binding of DMY to -amylase was studied by quenching of the intrinsic fluorescence of the protein. As shown in Figure 3 , binding of DMY to -amylase was accompanied by efficient quenching of the intrinsic fluorescence of the protein excited at 278 nm. The fluorescence intensity of -amylase decreased with increasing DMY concentration. In addition, adding DMY to -amylase resulted in the red shift of the maximum emission wavelength from 331 nm to 339 nm, as shown in Figure 3 . This red shift indicates the ground state complex formation between DMY and -amylase, and the changed conformation of the enzyme, as well as the increased polarity around the tryptophan residues.
The processes of fluorescence quenching are usually classified as either dynamic or static. The dynamic quenching constant (K q ) was determined by the Stern-Volmer equation,
where F 0 and F are the fluorescence intensities in the absence and presence of the quencher, respectively, K sv is the Stern-Volmer dynamic quenching constant, [Q] is the concentration of the quencher, K q is the biomolecular quenching constant, and  0 is the average lifetime of tryptophan in the trypsin system without quencher ( 0 =10 -8 s).
To assess the DMY/-amylase complex quenching constant, quenching of the tryptophan fluorescence by DMY in combination with the Stern-Volmer model is used here. As shown in Figure 4 , the Stern-Volmer plot for quenching of the tryptophan fluorescence by DMY showed good linearity in the range of quencher concentrations used in our experiments and provided the quenching constants K q = 8.537×10 13 L•mol -1 •S -1 . This value is greater than 2.0×10 10 L•mol -1 •S -1 , the maximum scatter collision quenching constant of various quenchers, which indicated that the overall quenching is dominated by a static quenching mechanism [16] .
Static quenching refers to fluorophore-quencher complex formation [17] . For the static quenching process, the binding constant (K a ) and Figure 5 , the binding constant K a was 1.11×10
5 L•mol -1 , and the number of binding sites (n) was 0.8495. Values of n approximately equal to 1 indicate the existence of a strong binding site in -amylase for DMY. The results are consistent with Xiao's research [13] . The -amylase-DMY complex formation possibly altered the environment of the active site or region close to the active site of the enzyme, which was responsible for the inhibition of enzymatic activity. The use of naturally occurring products for the development of small molecules as potential agents against -amylase activity is a hot topic in the food and pharmaceutical area. In this report, we have studied the complex formed between DMY and -amylase. The results showed that DMY can bind to -amylase and form a complex, which results in decreased antioxidant and catalytic activities of the enzyme, as well as efficient quenching of the intrinsic fluorescence of -amylase. The probable mechanism was a static quenching procedure and one -amylase molecule provided one binding site for a DMY molecule.
Experimental
Materials: -Amylase was purchased from Mühlenchemie GmbH Co. KG. 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and 2, 2′-azinobis Interaction of dihydromyricetin and -amylase Natural Product Communications Vol. 8 (3) 2013 341 (3-ethylbenzthiazoline-6-sulfonate) (ABTS) were obtained from Sigma Chemicals Co (USA). Other chemicals were of analytical grade and all aqueous solutions were prepared using doubledistilled water and maintained as phosphate buffer solutions (pH=7.0).
Extraction of DMY: DMY was extracted from
Ampelopsis grossedentata by microwave, dynamic, multi-stage, countercurrent extraction, as described by Li et al. [18] . The extraction conditions were 10 min extracting time for 5 stages, 2 min for every stage, 110 o C, 1∶30 material to solvent ratio, 600 W microwave power. The crude product was further purified by repeated organic solvent crystallization. After 5 recrystallizations with 60% ethanol, the purity of DMY reached 98%.
-Amylase inhibition assay:
The -amylase inhibition assay of Nickavar et al. was used, with some modification [19] . One hundred L of DMY solution (in DMSO) was mixed with 400 L of the -amylase solution (2.64 U/mL, in 20 mM sodium phosphate buffer containing 6.7 mM sodium chloride, pH 7.0) and incubated at 37°C for 30 min. A control with the mixture of 100 L DMSO and 400 L of the -amylase solution was also incubated at 37°C for 30 min. After incubation, 1 mL of 0.5% starch solution was added and the mixture was further incubated at 37°C for 5 min. The reaction was terminated with 1 mL of dinitrosalicyclic acid (DNS) color reagent and boiling for 15 min. After cooling to room temperature, the mixture was brought up to 25 mL with distilled water and the absorbance value was read at 540 nm. Individual blanks were prepared for correcting the background absorbance. In this case, the DNS color reagent solution was added prior to the addition of starch solution. The inhibition of -amylase activity was calculated by:
Inhibition of antioxidant activity: Fifty L of DMY solution (0.2 mg/mL, in ethanol) and different volumes of the -amylase solution (2.64 U/mL, in 20 mM sodium phosphate buffer containing 6.7 mM sodium chloride, pH 7.0) were mixed and diluted to 1 mL. Then, the mixture were incubated at 37°C for 30 min. Antioxidant activity of DMY was expressed as free radical (DPPH, ABTS) scavenging activity and reducing power. Inhibition of antioxidant activity was defined as percent difference between the measured increasing in antioxidant activity due to addition of -amylase compared with the calculated increase [5] . DPPH scavenging activity: DPPH scavenging activity of DMY was determined according to the method of Heo et al., with a slight modification [20] . Briefly, equal volumes of different concentrations of sample and freshly prepared DPPH solution were mixed. The reaction for scavenging DPPH radicals was carried out at room temperature for 30 min in the dark. The controls contained solvent instead of sample. The decrease in absorbance of DPPH at 517 nm was measured. The DPPH radical scavenging activity was expressed as the decrease of DPPH absorbance.
ABTS
•+ scavenging activity: ABTS •+ scavenging activity was determined according to the method of Riedl [21] . The ABTS
•+ was produced through the reaction between ABTS and potassium persulfate, stored in the dark at room temperature for 24 h. Before usage, the ABTS
•+ solution was diluted with sodium phosphate buffer (0.1 M, pH 7.4) to achieve an absorbance of 0.7 ± 0.02 at 734 nm. Then, 3 mL of ABTS
•+ solution and 1 mL of sample solution of different concentrations were mixed and incubated at room temperature for 30 min in the dark. The amount of ABTS scavenged corresponds to the difference in absorbance at 734 nm between the control and the sample.
Reducing power assay:
Reducing power was evaluated according to the method of Ardestani and Yazdanparast, with a slight modification [22] . Variable amounts of sample were mixed with 2.5 mL phosphate buffer (0.2 M, pH 6.6) and 2.5 mL potassium ferricyanide solution (1%, w/v), followed by incubation at 50°C for 20 min. The mixtures were then cooled and 2.5 mL trichloroacetic acid solution (10%, w/v) was added. After centrifugation at 3,000 rpm for 10 min, 2.5 mL of the supernatant solution was combined with 2.5 mL distilled water and 0.5 mL ferric chloride solution (0.1%, w/v). The absorbance was read at 700 nm.
Fluorescence quenching measurements:
Fluorometric experiments were carried out on a Hitachi F-7000 fluorescence spectrophotometer. One mL of -amylase solution (2.64 U/mL, in 20 mM sodium phosphate buffer containing 6.7 mM sodium chloride, pH 7.0) and 100 L of various concentrations of DMY solution were mixed and allowed to stand at room temperature for 30 min. The fluorescence spectra were recorded at  ex =278 nm and emission wavelength range of 290-450 nm.
